ロード中...
NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. NAFLD encompasses a spectrum of disease ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. However, despite the growing recognition of this i...
保存先:
| 出版年: | J Clin Exp Hepatol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995889/ https://ncbi.nlm.nih.gov/pubmed/32025168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.09.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|